心房颤动患者的心脏再同步治疗——值得付出努力吗？
Cardiac Resynchronization Therapy in Patients with Atrial Fibrillation - Worth the Effort?
作者信息
Ferreira António M, Carmo Pedro, Adragão Pedro
机构信息
Hospital Santa Cruz - Western Lisbon Hospital Centre, Lisbon, Portugal.
出版信息
J Atr Fibrillation. 2012 Apr 14;4(6):435. doi: 10.4022/jafib.435. eCollection 2012 Apr-May.
Abstract
Congestive heart failure (CHF) and atrial fibrillation (AF) are two increasingly common conditions that predispose to each other and frequently coexist. Cardiac resynchronization therapy(CRT) has emerged as an important therapeutic modality for selected patients with end-stage CHF. However, despite the high prevalence of AF in patients eligible for CRT, almost all the randomized clinical trials that validated the benefit of resynchronization therapy excluded patients with preexisting AF. In this review, we examine the available evidence on the benefits and limitations of CRT in patients with AF and discuss recent data that narrowed the knowledge gap on this topic.
摘要
充血性心力衰竭（CHF）和心房颤动（AF）是两种日益常见的疾病，它们相互影响且常常共存。心脏再同步治疗（CRT）已成为特定终末期CHF患者的重要治疗方式。然而，尽管符合CRT治疗条件的患者中AF患病率很高，但几乎所有证实再同步治疗益处的随机临床试验都排除了已患有AF的患者。在本综述中，我们研究了CRT治疗AF患者的益处和局限性的现有证据，并讨论了最近缩小该主题知识差距的数据。
相似文献
1
Cardiac Resynchronization Therapy in Patients with Atrial Fibrillation - Worth the Effort?心房颤动患者的心脏再同步治疗——值得付出努力吗？
J Atr Fibrillation. 2012 Apr 14;4(6):435. doi: 10.4022/jafib.435. eCollection 2012 Apr-May.
2
Case selection for cardiac resynchronization in atrial fibrillation.心房颤动患者心脏再同步治疗的病例选择。
Heart Fail Clin. 2013 Oct;9(4):461-74, ix. doi: 10.1016/j.hfc.2013.07.001. Epub 2013 Aug 21.
3
Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).心房颤动患者的心脏再同步治疗：CERTIFY 研究（心房颤动患者心脏再同步治疗多国注册研究）。
JACC Heart Fail. 2013 Dec;1(6):500-7. doi: 10.1016/j.jchf.2013.06.003. Epub 2013 Oct 23.
4
Atrial Fibrillation During Cardiac Resynchronization Therapy.心脏再同步治疗期间的心房颤动
Heart Fail Clin. 2017 Jan;13(1):179-192. doi: 10.1016/j.hfc.2016.07.014.
5
Atrial fibrillation and cardiac resynchronization therapy: the MASCOT study.心房颤动与心脏再同步治疗：MASCOT研究
Europace. 2004 Sep;5 Suppl 1:S49-54. doi: 10.1016/j.eupc.2004.07.007.
6
Resynchronization therapy in the context of atrial fibrillation: benefits and limitations.
J Interv Card Electrophysiol. 2007 Apr;18(3):225-32. doi: 10.1007/s10840-007-9092-2. Epub 2007 Apr 21.
7
Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.心房颤动患者的心脏再同步治疗：一项为期2年的随访研究。
Pacing Clin Electrophysiol. 2013 Jul;36(7):872-7. doi: 10.1111/pace.12136. Epub 2013 Apr 17.
8
Atrial Fibrillation During Cardiac Resynchronization Therapy.心脏再同步治疗期间的心房颤动
Card Electrophysiol Clin. 2015 Dec;7(4):735-48. doi: 10.1016/j.ccep.2015.08.005.
9
A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.一种新算法可增加心房颤动期间有效心脏再同步治疗的输送：CRTee 随机交叉试验。
Heart Rhythm. 2018 Mar;15(3):369-375. doi: 10.1016/j.hrthm.2017.10.026. Epub 2017 Nov 11.
10
Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.比较心房颤动伴或不伴房室结消融患者与窦性心律患者心脏再同步治疗的生存情况：系统评价和网络荟萃分析。
Heart Fail Rev. 2019 May;24(3):335-342. doi: 10.1007/s10741-018-9761-5.
引用本文的文献
1
Homogenization of Atrial Electrical Activities: Conceptual Restoration of Regional Electrophysiological Parameters to Deter Ischemia-Dependent Conflictogenic Atrial Fibrillation.心房电活动的同质化：将区域电生理参数概念性恢复以预防缺血依赖性致冲突性心房颤动。
J Atr Fibrillation. 2013 Aug 31;6(2):879. doi: 10.4022/jafib.879. eCollection 2013 Aug-Sep.
本文引用的文献
1
Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis.导管消融治疗左心室收缩功能障碍患者的心房颤动：系统评价和荟萃分析。
J Card Fail. 2011 Nov;17(11):964-70. doi: 10.1016/j.cardfail.2011.07.009. Epub 2011 Sep 9.
2
Association of rate-controlled persistent atrial fibrillation with clinical outcome and ventricular remodelling in recipients of cardiac resynchronization therapy.心脏再同步治疗患者的心率控制持续性心房颤动与临床转归和心室重构的关系。
Can J Cardiol. 2011 Nov-Dec;27(6):787-93. doi: 10.1016/j.cjca.2011.06.004. Epub 2011 Sep 9.
3
Percent biventricular pacing in cardiac resynchronization therapy: is more always better?
Heart Rhythm. 2011 Sep;8(9):1476-7. doi: 10.1016/j.hrthm.2011.04.025. Epub 2011 Apr 28.
4
Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival.心脏再同步治疗与双心室起搏百分比与症状和生存的关系。
Heart Rhythm. 2011 Sep;8(9):1469-75. doi: 10.1016/j.hrthm.2011.04.015. Epub 2011 Apr 15.
5
Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.房室结消融治疗永久性心房颤动患者的心脏再同步治疗：一项随机试验。
Eur Heart J. 2011 Oct;32(19):2420-9. doi: 10.1093/eurheartj/ehr162. Epub 2011 May 23.
6
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis.心脏再同步治疗在伴有和不伴有心房颤动的患者中的结局：系统评价和荟萃分析。
Heart Rhythm. 2011 Jul;8(7):1088-94. doi: 10.1016/j.hrthm.2011.02.014. Epub 2011 Feb 19.
7
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.2010年欧洲心脏病学会心力衰竭器械治疗指南重点更新：2008年欧洲心脏病学会急慢性心力衰竭诊断和治疗指南及2007年欧洲心脏病学会心脏再同步化治疗指南的更新。由心力衰竭协会和欧洲心律协会特别贡献制定。
Eur Heart J. 2010 Nov;31(21):2677-87. doi: 10.1093/eurheartj/ehq337. Epub 2010 Aug 27.
8
Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry.在国家心血管数据注册植入式心脏复律除颤器登记处登记的患者中，心脏再同步治疗的标签外使用的流行率和预测因素。
J Am Coll Cardiol. 2010 Aug 31;56(10):766-73. doi: 10.1016/j.jacc.2010.05.025.
9
Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation.药物治疗与消融治疗心房颤动：导管消融的证据支持。
Eur Heart J. 2010 May;31(9):1046-54. doi: 10.1093/eurheartj/ehq079. Epub 2010 Mar 23.
10
Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.房室结消融可预测接受心脏再同步治疗的房颤患者的生存获益。
Heart Rhythm. 2010 Sep;7(9):1240-5. doi: 10.1016/j.hrthm.2010.02.011. Epub 2010 Feb 13.
Zotero 插件